Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 7-Deazaguanines in DNA: functional and structural elucidation of a DNA modification system. | Nucleic Acids Res | 2023 | 36928176 | PubTator, text mining | PubMed |
| Chemotherapeutic-caused liver toxicity hinders nanomedicine development. | RSC Adv | 2023 | 36923299 | PubTator, text mining | PubMed |
| Discrepancies between dihydropyrimidine dehydrogenase phenotyping and genotyping: What are the explanatory factors? | Br J Clin Pharmacol | 2023 | 36918744 | PubTator, text mining | PubMed |
| Using a combination of fruquintinib, raltitrexed, and S-1 as a third-line treatment for metastatic colorectal cancer with co-existence of Hodgkin lymphoma: a case report. | J Gastrointest Oncol | 2023 | 36915460 | PubTator, text mining | PubMed |
| A Brief Review on Chemoresistance; Targeting Cancer Stem Cells as an Alternative Approach. | Int J Mol Sci | 2023 | 36901917 | PubTator, text mining | PubMed |
| Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. | Cancers (Basel) | 2023 | 36900216 | PubTator, text mining | PubMed |
| Precision fluoropyrimidines dosing in a compound heterozygous variant carrier of the DPYD gene: a case report. | Cancer Chemother Pharmacol | 2023 | 36890284 | PubTator, text mining | PubMed |
| Fluorouracil-induced leukoencephalopathy mimicking neuroleptic malignant syndrome: a case report. | J Med Case Rep | 2023 | 36882809 | PubTator, text mining | PubMed |
| Characterization of bone marrow heterogeneity in NK-AML (M4/M5) based on single-cell RNA sequencing. | Exp Hematol Oncol | 2023 | 36879313 | PubTator, text mining | PubMed |
| Systems-level multi-omics characterization provides novel molecular insights into indomethacin toxicity. | Chem Biol Interact | 2023 | 36868495 | PubTator, text mining | PubMed |
| Differentially Expressed Heterogeneous Overdispersion Genes Testing for Count Data. | bioRxiv | 2023 | 36865247 | PubTator, text mining | PubMed |
| PSnpBind-ML: predicting the effect of binding site mutations on protein-ligand binding affinity. | J Cheminform | 2023 | 36864534 | PubTator, text mining | PubMed |
| Comprehensive characterization of the genetic landscape of familial Hirschsprung's disease. | World J Pediatr | 2023 | 36857021 | PubTator, text mining | PubMed |
| Short-term biological variation of plasma uracil in a Caucasian healthy population. | Clin Chem Lab Med | 2023 | 36856054 | PubTator, text mining | PubMed |
| Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment. | Alzheimers Res Ther | 2023 | 36855162 | PubTator, text mining | PubMed |
| Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumors. | J Cancer Res Clin Oncol | 2023 | 36854800 | PubTator, text mining | PubMed |
| A review of pharmacogenetic studies in the Bangladeshi population. | Drug Metab Pers Ther | 2023 | 36854045 | PubTator, text mining | PubMed |
| Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. | Signal Transduct Target Ther | 2023 | 36843114 | PubTator, text mining | PubMed |
Excluding Digenic Inheritance of PGAP2 and PGAP3 Variants in Mabry Syndrome (OMIM 239300) Patient: Phenotypic Spectrum Associated with PGAP2 Gene Variants in Hyperphosphatasia with Mental Retardation Syndrome-3 (HPMRS3). | Genes (Basel) | 2023 | 36833286 | PubTator, text mining | PubMed |
| Cell-free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients. | Mol Oncol | 2023 | 36825535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=30